Hypertension, Pregnancy-Induced
38
3
5
24
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.6%
1 terminated out of 38 trials
96.0%
+9.5% vs benchmark
24%
9 trials in Phase 3/4
38%
9 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (38)
Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy
LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
Wearables to Define Postpartum Blood Pressure Trajectories and Facilitate Evidence-based Monitoring Guidelines
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Postpartum Hypertension: Remote Patient Monitoring
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
Lasix for the Prevention of De Novo Postpartum Hypertension
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Arm and Finger Measurement for Blood Pressure Surveillance
Furosemide vs. Placebo for Severe Antepartum Hypertension
Breastfeeding and Postpartum Cardiovascular Health
Hypertension In Postpartum Preeclampsia Study
An mHealth Strategy to Reduce Pre-Eclampsia and Infant Death in Tanzania
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
Postpartum Management of Gestational Hypertensive Disorders Using Furosemide
Low Dose Calcium to Prevent Preeclampsia
Fibroblast Growth Factor 23 and Hypertensive Disorder Complicating Pregnancy
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension